Clinical Trials Directory

Trials / Conditions / Atypical Chronic Myeloid Leukemia

Atypical Chronic Myeloid Leukemia

8 registered clinical trials studyying Atypical Chronic Myeloid Leukemia — 4 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingRopeginterferon Alfa-2b for the Treatment of Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Synd
NCT07468916
Jonsson Comprehensive Cancer CenterPhase 2
RecruitingOptimization of Post-transplantation Benadamustine and Cyclophosphamide in Patients With High-risk Myeloid Mal
NCT07238712
St. Petersburg State Pavlov Medical UniversityPhase 2
RecruitingAxatilimab With or Without Azacitidine for the Treatment of Patients With Advanced Phase Myeloproliferative Ne
NCT06523556
Uma BoratePhase 1 / Phase 2
Active Not RecruitingStudy of a Geriatric Assessment to Plan a Treatment Approach for Older People With Various Blood Disorders
NCT04761770
Memorial Sloan Kettering Cancer CenterPhase 2
RecruitingHyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant
NCT03964506
Omar AljitawiEARLY_Phase 1
Active Not RecruitingTopotecan Hydrochloride and Carboplatin With or Without Veliparib in Treating Advanced Myeloproliferative Diso
NCT03289910
National Cancer Institute (NCI)Phase 2
WithdrawnPacritinib in Combination With Low Dose Decitabine in Intermediate-High Risk Myelofibrosis or Myeloproliferati
NCT02564536
Washington University School of MedicinePhase 1
CompletedBeclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem
NCT00489203
Fred Hutchinson Cancer CenterPhase 2